Analyze Diet
Journal of the National Cancer Institute1976; 56(2); 365-368; doi: 10.1093/jnci/56.2.365

Radiotherapy of spontaneous fibrous connective-tissue sarcomas in animals.

Abstract: The clinical records and follow-up data obtained over 13 years on the results of radiotherapy of spontaneous fibrous connective-tissue sarcomas in dogs, cats, and horses were reviewed. The results obtained from the treatment of fibrosarcomas and sarcoids of horses indicated that radiation administered with 60Co is important in the medical and surgical management of these tumors. Fibrous connective-tissue sarcomas in horses were radioresponsive. When radiotherapy was applied postoperatively, the probability of a 2-year cure approached 50% for all prescribed radiation doses of less than 2,000 to greater than 4,000 rads. If radiation doses of 4,500-6,000 rads were used, a 2-year cure rate may approach or exceed 60%.
Publication Date: 1976-02-01 PubMed ID: 1255767DOI: 10.1093/jnci/56.2.365Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research study reviewed 13 years of clinical records on the use of radiotherapy for treating fibrous connective-tissue sarcomas in animals, specifically dogs, cats, and horses. The results indicate that radiotherapy, particularly when used after surgery, significantly improves the chances of a 2-year cure for these types of tumors. Higher radiation doses further increased the cure rate.

Overview of Research

  • The study focused on the review of clinical records and follow-up data over a period of 13 years.
  • The objective was to determine the efficacy of radiotherapy in treating spontaneous fibrous connective-tissue sarcomas in animals.
  • The study included animals such as dogs, cats, and horses.

Findings of the Study

  • The treatment yielded significant results in the case of fibrosarcomas and sarcoids in horses, suggesting that radiation, particularly administered with cobalt-60 (60Co), plays a crucial role in the management of these tumors.
  • It was observed that fibrous connective-tissue sarcomas in horses responded well to radiation treatment.
  • The use of radiotherapy post-operation increased the likelihood of a 2-year cure to almost 50%, provided that the radiation doses ranged between less than 2,000 to greater than 4,000 rads.

Effects of Higher Radiation Doses

  • The study found an interesting correlation between dosage and cure rates – higher doses led to higher cure rates.
  • If radiation doses were between 4,500-6,000 rads, a 2-year cure rate could approach or even exceed 60%.

Implications of the Study

  • The findings enrich our existing knowledge regarding the use of radiotherapy in veterinary medicine, especially in the treatment of fibrous connective-tissue sarcomas.
  • The results shed light on the importance of radiation dosage and timing (post-operation) in significantly enhancing cure rates.
  • While the study specifically refers to horses, given the inclusion of other animals like dogs and cats, further research may uncover similar benefits for these and other animals.

Cite This Article

APA
Hilmas DE, Gillette EL. (1976). Radiotherapy of spontaneous fibrous connective-tissue sarcomas in animals. J Natl Cancer Inst, 56(2), 365-368. https://doi.org/10.1093/jnci/56.2.365

Publication

ISSN: 0027-8874
NlmUniqueID: 7503089
Country: United States
Language: English
Volume: 56
Issue: 2
Pages: 365-368

Researcher Affiliations

Hilmas, D E
    Gillette, E L

      MeSH Terms

      • Animals
      • Cat Diseases / radiotherapy
      • Cats
      • Cobalt Radioisotopes
      • Dog Diseases / radiotherapy
      • Dogs
      • Fibrosarcoma / radiotherapy
      • Fibrosarcoma / veterinary
      • Horse Diseases / radiotherapy
      • Horses
      • Prognosis
      • Radiotherapy Dosage
      • Sarcoma / radiotherapy

      Citations

      This article has been cited 3 times.
      1. Woodward KN. Origins of injection-site sarcomas in cats: the possible role of chronic inflammation-a review. ISRN Vet Sci 2011;2011:210982.
        doi: 10.5402/2011/210982pubmed: 23738095google scholar: lookup
      2. Mir LM, Devauchelle P, Quintin-Colonna F, Delisle F, Doliger S, Fradelizi D, Belehradek J Jr, Orlowski S. First clinical trial of cat soft-tissue sarcomas treatment by electrochemotherapy. Br J Cancer 1997;76(12):1617-22.
        doi: 10.1038/bjc.1997.606pubmed: 9413951google scholar: lookup
      3. Klein WR, Bras GE, Misdorp W, Steerenberg PA, de Jong WH, Tiesjema RH, Kersjes AW, Ruitenberg EJ. Equine sarcoid: BCG immunotherapy compared to cryosurgery in a prospective randomised clinical trial. Cancer Immunol Immunother 1986;21(2):133-40.
        doi: 10.1007/BF00199861pubmed: 3633215google scholar: lookup